These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 38842135

  • 1. Amentoflavone reverses epithelial-mesenchymal transition in hepatocellular carcinoma cells by targeting p53 signalling pathway axis.
    Jian HY, Zhang JT, Liu Z, Zhang Z, Zeng PH.
    J Cell Mol Med; 2024 Jun; 28(11):e18442. PubMed ID: 38842135
    [Abstract] [Full Text] [Related]

  • 2. Dendrobium nobile active ingredient Dendrobin A against hepatocellular carcinoma via inhibiting nuclear factor kappa-B signaling.
    Yu Y, Fan Y, Mei W, Xu X, Chen Y, Zhao Y, Ruan B, Shen Z, Lu Y, Zheng S, Jie W.
    Biomed Pharmacother; 2024 Aug; 177():117013. PubMed ID: 38901205
    [Abstract] [Full Text] [Related]

  • 3. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK-VEGF/MMPs signaling pathway.
    Tian L, Huang Y, Liu Y, Liu J, Liu Y.
    IUBMB Life; 2024 Nov; 76(11):972-986. PubMed ID: 38873890
    [Abstract] [Full Text] [Related]

  • 4. Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma In Vitro.
    Lee KC, Tsai JJ, Tseng CW, Kuo YC, Chuang YC, Lin SS, Hsu FT.
    In Vivo; 2018 Nov; 32(3):549-554. PubMed ID: 29695559
    [Abstract] [Full Text] [Related]

  • 5. Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells.
    Wu Q, Wang X, Liu J, Zheng J, Liu Y, Li Y, Su F, Ou W, Wang R.
    Oncol Rep; 2016 Sep; 36(3):1325-32. PubMed ID: 27430152
    [Abstract] [Full Text] [Related]

  • 6. β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression.
    Wang R, Tang D, Ou L, Jiang J, Wu YN, Tian X.
    Hum Cell; 2024 Jul; 37(4):1156-1169. PubMed ID: 38814517
    [Abstract] [Full Text] [Related]

  • 7. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF, Feng KL, Wang JN, Luo R, Fang CK, Zhang Y, Shen CP, Zhong C.
    J Ethnopharmacol; 2022 Aug 10; 294():115360. PubMed ID: 35568116
    [Abstract] [Full Text] [Related]

  • 8. Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis.
    Hidalgo F, Ferretti AC, Etichetti CB, Baffo E, Pariani AP, Maknis TR, Bussi J, Girardini JE, Larocca MC, Favre C.
    Sci Rep; 2024 Sep 11; 14(1):21275. PubMed ID: 39261583
    [Abstract] [Full Text] [Related]

  • 9. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
    Yin W, Xu J, Li C, Dai X, Wu T, Wen J.
    Cell Biol Int; 2020 Aug 11; 44(8):1616-1627. PubMed ID: 32239594
    [Abstract] [Full Text] [Related]

  • 10. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
    Gong QZ, Xiao D, Gong GY, Xu J, Wen XD, Feng F, Qu W.
    Curr Cancer Drug Targets; 2019 Aug 11; 19(7):583-593. PubMed ID: 30585547
    [Abstract] [Full Text] [Related]

  • 11. Phenethyl isothiocyanate inhibits the carcinogenic properties of hepatocellular carcinoma Huh7.5.1 cells by activating MAPK/PI3K-Akt/p53 signaling pathways.
    Du J, Zhang Y, Chen J, Jin L, Pan L, Lei P, Lin S.
    PeerJ; 2024 Aug 11; 12():e17532. PubMed ID: 38873643
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy.
    Wang Y, Su L, Hu Z, Peng S, Li N, Fu H, Wang B, Wu H.
    Apoptosis; 2024 Oct 11; 29(9-10):1429-1453. PubMed ID: 39023830
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 11; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X, Du YP, Zhao XC.
    Exp Biol Med (Maywood); 2018 Apr 11; 243(7):645-654. PubMed ID: 29486578
    [Abstract] [Full Text] [Related]

  • 19. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma.
    Xia P, Zhang H, Xu K, Jiang X, Gao M, Wang G, Liu Y, Yao Y, Chen X, Ma W, Zhang Z, Yuan Y.
    Cell Death Dis; 2021 Jul 09; 12(7):691. PubMed ID: 34244479
    [Abstract] [Full Text] [Related]

  • 20. Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition.
    Fang T, Fang Y, Xu X, He M, Zhao Z, Huang P, Yuan F, Guo M, Yang B, Xia J.
    J Ethnopharmacol; 2019 Mar 01; 231():474-485. PubMed ID: 30415058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.